Related Experiment Video
Updated: Oct 1, 2026

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
Published on: May 10, 2017
Interleukin 17: an example for gene therapy as a tool to study cytokine mediated regulation of hematopoiesis
Paul Schwarzenberger1, Jay K Kolls
1Gene Therapy Program, Louisiana State University Health Sciences Center of New Orleans, 70112, USA. pschwa1@lsuhsc.edu
Abstract:
Interleukin 17 (IL-17) is an essential proinflammatory T-cell derived cytokine with various biological actions. IL-17 was found to have a pivotal role in microbial host defense by interconnecting lymphoid and myeloid host defense. It also acts as a stimulatory hematopoietic cytokine by expanding myeloid progenitors and initiating proliferation of mature neutrophils. This article summarizes results to date on IL-17 research and discusses gene therapy based strategies that were employed to determine its biological functions and significance. A comprehensive working model for IL-17 is introduced.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

